Discontinued — last reported Q4 '25
Ferguson Enterprises Interest Paid decreased by 70.7% to $22.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.8%, from $19.00M to $22.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.50M | $23.50M | $23.50M | $23.50M | $70.00M | $97.00M | $65.00M | $74.00M | $19.00M | $152.00M | $75.00M | $22.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +197.9% | +38.6% | -33.0% | +13.8% | -74.3% | +700.0% | -50.7% | -70.7% |
| YoY Change | — | — | — | — | +197.9% | — | — | +5.7% | -80.4% | +133.8% | +1.4% | +15.8% |